Selected passages from the FDA letter
Quoted FDA text from the published dataset. These selected excerpts are not the complete letter.
Passage 1your website offers Full-Spectrum Hemp Oil and cannabidiol (CBD) products for sale in the United States and that these products are intended to mitigate, prevent, treat, diagnose, or cure COVID-19***1*** in people.
Passage 2these products are unapproved new drugs sold in violation of section 505(a) of the Federal Food, Drug, and Cosmetic Act (FD&C Act), 21 U.S.C. § 355(a).
Passage 3these products are misbranded drugs under section 502 of the FD&C Act, 21 U.S.C. § 352.
Passage 4Hemp Oil has been shown to possibly reduce viral inflammation, known as a cytokines storm, which can be detrimental and even deadly to a person suffering from a viral infection, such as COVID-19.
Passage 5Cannabinoids may decrease the number of receptors available to the virus giving your body more of a chance to fight it.